Lin X, Wu Q, Lei W, Wu D, Sheng J, Liang G
Cell Div. 2024; 19(1):30.
PMID: 39487468
PMC: 11529598.
DOI: 10.1186/s13008-024-00134-w.
Kalofonou F, Leach D, Powell S, Waxman J, Fletcher C, Bevan C
Front Oncol. 2024; 14:1440612.
PMID: 39267821
PMC: 11390458.
DOI: 10.3389/fonc.2024.1440612.
Li S, Xiong F, Zhang S, Liu J, Gao G, Xie J
Mol Ther Nucleic Acids. 2024; 35(2):102184.
PMID: 38665220
PMC: 11044058.
DOI: 10.1016/j.omtn.2024.102184.
Lin L, Wu Q, Lu F, Lei J, Zhou Y, Liu Y
Front Oncol. 2023; 13:1184079.
PMID: 37810967
PMC: 10559910.
DOI: 10.3389/fonc.2023.1184079.
Villarreal-Garcia V, Estupinan-Jimenez J, Vivas-Mejia P, Gonzalez-Villasana V, Vazquez-Guillen J, Resendez-Perez D
Front Oncol. 2022; 12:980694.
PMID: 36226048
PMC: 9548555.
DOI: 10.3389/fonc.2022.980694.
Recent insights into the microRNA-dependent modulation of gliomas from pathogenesis to diagnosis and treatment.
Mafi A, Rahmati A, Babaei Aghdam Z, Salami R, Salami M, Vakili O
Cell Mol Biol Lett. 2022; 27(1):65.
PMID: 35922753
PMC: 9347108.
DOI: 10.1186/s11658-022-00354-4.
Effects of Exosomal Viral Components on the Tumor Microenvironment.
Li J, Zhang Y, Luo B
Cancers (Basel). 2022; 14(14).
PMID: 35884611
PMC: 9317196.
DOI: 10.3390/cancers14143552.
Technological Approaches in the Analysis of Extracellular Vesicle Nucleotide Sequences.
Tesovnik T, Jenko Bizjan B, Sket R, Debeljak M, Battelino T, Kovac J
Front Bioeng Biotechnol. 2022; 9:787551.
PMID: 35004647
PMC: 8733665.
DOI: 10.3389/fbioe.2021.787551.
A Systematic Review of MicroRNA Signatures Associated with the Progression of Leukoplakia with and without Epithelial Dysplasia.
Kaunein N, Ramani R, Koo K, Moore C, Celentano A, McCullough M
Biomolecules. 2021; 11(12).
PMID: 34944523
PMC: 8699326.
DOI: 10.3390/biom11121879.
Nanoliposomal Delivery of MicroRNA-203 Suppresses Migration of Triple-Negative Breast Cancer through Distinct Target Suppression.
Song S, Johnson K, Lujan H, Pradhan S, Sayes C, Taube J
Noncoding RNA. 2021; 7(3).
PMID: 34449670
PMC: 8395754.
DOI: 10.3390/ncrna7030045.
Emerging urinary alpha-synuclein and miRNA biomarkers in Parkinson's disease.
Giri B, Seamon M, Banerjee A, Chauhan S, Purohit S, Morgan J
Metab Brain Dis. 2021; 37(6):1687-1696.
PMID: 33881722
DOI: 10.1007/s11011-021-00735-2.
miR-369 inhibits Liver Cancer progression by targeting ZEB1 pathway and predicts the prognosis of HCC patients.
Dong Y, Li F, Wang J, Hu J, Li Z, Gu Y
J Cancer. 2021; 12(10):3067-3076.
PMID: 33854606
PMC: 8040887.
DOI: 10.7150/jca.54759.
Does Calorie Restriction Modulate Inflammaging via FoxO Transcription Factors?.
Kim S, Mori R, Shimokawa I
Nutrients. 2020; 12(7).
PMID: 32630045
PMC: 7399912.
DOI: 10.3390/nu12071959.
MicroRNA-196a promotes cell proliferation and inhibits apoptosis in human ovarian cancer by directly targeting DDX3 and regulating the PTEN/PI3K/AKT signaling pathway.
Ni J, Chen L, Ling L, Wu M, Ren Q, Zhu W
Mol Med Rep. 2020; 22(2):1277-1284.
PMID: 32626994
PMC: 7339644.
DOI: 10.3892/mmr.2020.11236.
MiR-6803-5p Promotes Cancer Cell Proliferation and Invasion via PTPRO/NF-B Axis in Colorectal Cancer.
Yan S, Cheng M, Duan Q, Wang Z, Gao W, Ren B
Mediators Inflamm. 2019; 2019:8128501.
PMID: 31827380
PMC: 6886338.
DOI: 10.1155/2019/8128501.
Highly efficient silencing of microRNA by heteroduplex oligonucleotides.
Yoshioka K, Kunieda T, Asami Y, Guo H, Miyata H, Yoshida-Tanaka K
Nucleic Acids Res. 2019; 47(14):7321-7332.
PMID: 31214713
PMC: 6698647.
DOI: 10.1093/nar/gkz492.
MicroRNA-152 Inhibits Cell Proliferation, Migration, and Invasion in Breast Cancer.
Maimaitiming A, Wusiman A, Aimudula A, Kuerban X, Su P
Oncol Res. 2019; 28(1):13-19.
PMID: 30982494
PMC: 7851537.
DOI: 10.3727/096504019X15519249902838.
Hsa-miR-376c-3p targets Cyclin D1 and induces G1-cell cycle arrest in neuroblastoma cells.
Bhavsar S, Lokke C, Flaegstad T, Einvik C
Oncol Lett. 2018; 16(5):6786-6794.
PMID: 30405823
PMC: 6202480.
DOI: 10.3892/ol.2018.9431.
Non-coding RNAs in cancer diagnosis and therapy.
Rasool M, Malik A, Zahid S, Ashraf M, Qazi M, Asif M
Noncoding RNA Res. 2018; 1(1):69-76.
PMID: 30159413
PMC: 6096421.
DOI: 10.1016/j.ncrna.2016.11.001.
Targeting of HER3 with Functional Cooperative miRNAs Enhances Therapeutic Activity in HER2-Overexpressing Breast Cancer Cells.
Lyu H, Huang J, He Z, Liu B
Biol Proced Online. 2018; 20:16.
PMID: 30093840
PMC: 6081814.
DOI: 10.1186/s12575-018-0081-x.